Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
Journal of the Society for Gynecologic Investigation
|
June 29, 2004
Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development
Jayanthi S Lea, Raheela Ashfaq, Sabeeha Muneer, et al.
Journal of Surgical Oncology
|
February 7, 2018
Pre-operative core muscle index in combination with hypoalbuminemia is associated with poor prognosis in advanced ovarian cancer
Lesley B Conrad, Haitham Awdeh, Stefany Acosta-Torres, et al.
American Journal of Clinical Oncology
|
December 8, 2025
Impact of Interruptions in Chemotherapy on Survival for Patients With Metastatic or Recurrent Cervical Cancer
Risha Sinha, Arianna Portmann-Baracco, April R Gorman, et al.
Gynecologic Oncology
|
April 22, 2008
Implications of EGFR inhibition in ovarian cancer cell proliferation
Shawna L Bull Phelps, John O Schorge, Michael J Peyton, et al.
Gynecologic Oncology
|
December 26, 2001
Stage IIB-IVB cervical adenocarcinoma: prognostic factors and survival
Jayanthi S Lea, Ellen E Sheets, Robert M Wenham, et al.
Gynecologic Oncology
|
July 19, 2015
Ovarian involvement in endometrioid adenocarcinoma of uterus
Ken Y Lin, David S Miller, April A Bailey, et al.
American Journal of Clinical Oncology
|
June 4, 2016
Locally Advanced Cervical Cancer: Outcomes With Variable Adherence to Treatment
Dustin B Manders, Abel Morón, Donald McIntire, et al.
Elife
|
January 21, 2021
Identification of PARP-7 substrates reveals a role for MARylation in microtubule control in ovarian cancer cells
Lavanya H Palavalli Parsons, Sridevi Challa, Bryan A Gibson, et al.
Cancer Research Communications
|
May 20, 2024
Nucleolar Localization of the RNA Helicase DDX21 Predicts Survival Outcomes in Gynecologic Cancers
Marwa W Aljardali, Kevin M Kremer, Jessica E Parker, et al.
American Journal of Clinical Oncology
|
August 18, 2017
Hypoalbuminemia is a Predictive Factor for Fistula Formation in Recurrent Cervical Cancer
Lavanya H Palavalli Parsons, Brandon Roane, Dustin B Manders, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
Journal of the Society for Gynecologic Investigation
|
June 29, 2004
Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development
Jayanthi S Lea, Raheela Ashfaq, Sabeeha Muneer, et al.
Journal of Surgical Oncology
|
February 7, 2018
Pre-operative core muscle index in combination with hypoalbuminemia is associated with poor prognosis in advanced ovarian cancer
Lesley B Conrad, Haitham Awdeh, Stefany Acosta-Torres, et al.
American Journal of Clinical Oncology
|
December 8, 2025
Impact of Interruptions in Chemotherapy on Survival for Patients With Metastatic or Recurrent Cervical Cancer
Risha Sinha, Arianna Portmann-Baracco, April R Gorman, et al.
Gynecologic Oncology
|
April 22, 2008
Implications of EGFR inhibition in ovarian cancer cell proliferation
Shawna L Bull Phelps, John O Schorge, Michael J Peyton, et al.
Gynecologic Oncology
|
December 26, 2001
Stage IIB-IVB cervical adenocarcinoma: prognostic factors and survival
Jayanthi S Lea, Ellen E Sheets, Robert M Wenham, et al.
Gynecologic Oncology
|
July 19, 2015
Ovarian involvement in endometrioid adenocarcinoma of uterus
Ken Y Lin, David S Miller, April A Bailey, et al.
American Journal of Clinical Oncology
|
June 4, 2016
Locally Advanced Cervical Cancer: Outcomes With Variable Adherence to Treatment
Dustin B Manders, Abel Morón, Donald McIntire, et al.
Elife
|
January 21, 2021
Identification of PARP-7 substrates reveals a role for MARylation in microtubule control in ovarian cancer cells
Lavanya H Palavalli Parsons, Sridevi Challa, Bryan A Gibson, et al.
Cancer Research Communications
|
May 20, 2024
Nucleolar Localization of the RNA Helicase DDX21 Predicts Survival Outcomes in Gynecologic Cancers
Marwa W Aljardali, Kevin M Kremer, Jessica E Parker, et al.
American Journal of Clinical Oncology
|
August 18, 2017
Hypoalbuminemia is a Predictive Factor for Fistula Formation in Recurrent Cervical Cancer
Lavanya H Palavalli Parsons, Brandon Roane, Dustin B Manders, et al.
Page
of 6